【摘 要】
:
CHK抑制剂是一种DNA损伤治疗的有效药物。近来,组蛋白去乙酰化酶抑制剂显示对几种癌症有效,包括非霍奇金淋巴瘤。为了评估上述两种小分子抑制剂联合应用对人淋巴瘤的治疗效果,我们通过体内和体外实验评价了AR42(组蛋白去乙酰化酶抑制剂)和CHK Ⅱ抑制剂联合治疗的效果。
【机 构】
:
中国医学科学院北京协和医院;美国北加州退伍军人医疗中心;加州大学戴维斯医疗中心 加州大学戴维斯医疗
论文部分内容阅读
CHK抑制剂是一种DNA损伤治疗的有效药物。近来,组蛋白去乙酰化酶抑制剂显示对几种癌症有效,包括非霍奇金淋巴瘤。为了评估上述两种小分子抑制剂联合应用对人淋巴瘤的治疗效果,我们通过体内和体外实验评价了AR42(组蛋白去乙酰化酶抑制剂)和CHK Ⅱ抑制剂联合治疗的效果。
其他文献
The World Organisation for Animal Health (OIE) is an inter-governmental standard-setting organisation responsible for improving animal health and welfare and veterinary public health worldwide.Since i
狂犬病作为人畜共患的世界性疾病,也是迄今为止人类唯一病死率高达100%的急性传染病.据卫生部发布的《中国狂犬病防治现状》统计,中国年均因狂犬病导致死亡的人数达2400人以上,居全球第二位.由于人们对狂犬病的恐惧,全球范围内每年约有2000万犬只被无辜扑杀,每一分钟就有38条犬因此丧命.
20世纪90年代初,随着狂犬疫苗的推广,尤其是1993年浓缩狂犬疫苗的应用,江苏省狂犬病疫情逐年下降,1996年仅有病例11例报告,流行趋势与全国基本一致,90年代末,疫情再度回升,至2004年达到高峰.近年来疫情虽保持平稳下降状态,但人狂犬病死亡数在所有法定报告传染病中始终位居前列,2004年至2013年疫情流行造成的PYLL为26100人年,合计PYLLR及SPYLLR总体均呈下降趋势(线性回
Gregorio Torres obtained his veterinary degree in Cordoba University (Spain) and continued his postgraduate education in Glasgow University and London University where he specialised in veterinary epi
Although rabies can be effectively prevented after recognized exposures, there is no established effective therapy for human rabies.The Milwaukee protocol, consisting of therapeutic coma, ketamine, ri
Scalable, high quality cell manufacturing is key to providing safe, effective and economically viable cell therapies.In the case of autologous T-cell therapies this entails, high density expansion of
Oncolytic viruses have been utilized for the treatment of various cancers.However, delivery of the viral particles to tumor cells remains a major challenge.Microparticles (MPs) are vesicle forms of pl
肿瘤治疗性疫苗多数临床研究疗效有限.美国FDA批准上市的前列腺癌DC疫苗Provenge,其生存期与对照组相比提高了4.1个月,虽然有效,但距离人们的期望值尚远.人们也期望应用肿瘤干细胞样疫苗获取更好的疗效.
Background and purpose: It was a fact that Igs was overexpressed in many non B cell-derived cancer cells, moreover, its function, at least, the IgG was found to be directly involved in carcinogenesis.
For a robust and universal oncolytic adenoviral cancer treatment, we have constructed a promoter library consisting of Hsp-70 promoter and a combination of the trimeric cis-elements, which are shared